Table 3.
Compound | Class of Compound | Plant Source | Antiviral Effects | Reference |
---|---|---|---|---|
Andrographolide | Diterpenoid | Andrographis paniculata | Anti-DENV activity in HepG2 (EC50 = 21.304 µM) and HeLa cell lines (EC50 = 22.739 µM) | [118] |
Good anti-DENV effects in both visual (EC50 = 0.56 µg/mL) and neutral red cytopathic effects (EC50 = 0.58 µg/mL) | [129] | |||
Reduced mean number of A. aegypti eggs and increased larvae mortality concentration-dependently | [119] | |||
Delayed disease onset, reduced mortality and DENV-1, DENV-2, DENV-3 and DENV-4 loads in infected mouse brains | [130] | |||
Apiofuranoside | Flavanone glycosides | Faramea bahiensis | Controlled viral replication and reduced numbers of infected cells (12%) and RNA copies of DENV-2 (67%) in HepG2 cells | [104] |
Betulinic acid 3ß-caffeate | Phenyl terpenoid | Flacourtia ramontchi | Inhibited DENV replication (IC50 = 0.85 µM) |
[103] |
Caffeoylcalleryanin | Phenolic glycoside | Arrabidaea pulchra | Anti-DENV-2 activity (IC50 = 2.8 µg/mL) |
[84] |
Cardamonin | Phenolic | Boesenbergia rotunda | Non-competitive anti-DENV activity | [37] |
Castanospermine | Alkaloid | Castanospermine australe | Inhibited secretion and infectivity in all DENV serotypes in vitro. Only inhibited DENV-2 in vivo and prevented mouse mortality. |
[120] |
Chartaceones 1 | Dialkylated flavanone | Crypotocarya chartacea | Inhibited NS5 RdRp (IC50 = 14.8 µM) |
[127] |
Chartaceones 2 | Inhibited NS5 RdRp (IC50 = 72.7 µM) |
[127] | ||
Chartaceones 3 | Inhibited NS5 RdRp (IC50 = 4.2 µM) |
[127] | ||
Chartaceones 4 | Inhibited NS5 RdRp (IC50 = 1.8 µM) |
[127] | ||
Chartaceones 5 | Inhibited NS5 RdRp (IC50 = 2.9 µM) |
[127] | ||
Chartaceones 6 | Inhibited NS5 RdRp (IC50 = 2.4 µM) |
[127] | ||
Chlorogenic acid | Phenolic acid | Houttuynia cordata | Synergistic antiviral effect of combined hyperoside and chlorogenic acid | [109] |
Ellagic acid | Phenolic acid | Spondias mombin and Spondias tuberosa | Anti-DENV-2 (25%) at 500 µg/mL | [85] |
Flacourtoside A | Phenolic glycoside | Flacourtia ramontchi | Inhibited DENV replication (IC50 = 9.3 µM) |
[103] |
Flacourtoside B | Inhibited DENV replication (IC50 = 71.1 µM) |
|||
Flacourtoside C | Inhibited DENV replication (IC50 = 23.8 µM) |
|||
Flacourtoside D | Inhibited DENV replication (IC50 = 35.5 µM) |
|||
Flacourtoside E | Inhibited DENV replication (IC50 = 13.4 µM) |
|||
Flacourtoside F | Inhibited DENV replication (IC50 = 39.8 µM) |
|||
Fucoidan | Sulfated polysaccharide | Cladosiphon okamuranus | Inhibited DENV-2 Reduced infectivity by 20% at 10 µg/mL in BHK-21 cells | [121] |
Galactan | Sulfated polysaccharide | Cryptomenia crenulate | Inhibited DENV-2 and DENV-3 replication in Vero cells (IC50 = 1.0 µg/mL), slight inhibitory effect against DENV-4, inactive against DENV-1 | [122] |
Gymnogongrus tolulosus | Inhibited DENV-2 and DENV-3 replication in Vero cells (IC50 = 0.19–1.7 µg/mL) | [123] | ||
Galactomannan | Polysaccharride | Mimosa scabrella | Reduced DENV-1 titer 100-fold in C6/36 cells at 347 mg/L | [131] |
Leucaena leucocephala | Reduced DENV-1 titer 100-fold in C6/36 cells at 37 mg/L | [131] | ||
Glabranine | Flavanone | Tephrosia species | Anti-DENV (70% inhibition) at 25 µM | [132] |
Hyperoside | Flavonol glycoside | Houttuynia cordata | Synergistic antiviral effect of combination of hyperoside and chlorogenic acid | [109] |
4-Hydroxy-panduratin A | Phenolic derivative | Boesenbergia rotunda | Competitive inhibitory activity against DENV-2 NS3 protease (K1 = 21 µM) | [37] |
Kappa carrageenan | Sulfated polysaccharide | Gymnogongrus griffithsiae | Selectivity inhibited DENV-2 (IC50 = 0.9 µg/mL), DENV-3 and DENV-4 replication. Inactive against DENV-1 | [122] |
Meristiella gelidium | Anti-DENV-2 activity (IC50 between 0.14–1.6 µg/mL) | [125] | ||
7-O-methyl-glabranine | Flavanone | Tephrosia species | Exhibited 70% inhibition on DENV in a plaque-forming assay at 25 µM | [132] |
Methyl gallate | Phenolic acid | Quercus lusitanica | Inhibited DENV-2 protease (98%) at 0.3 mg/mL | [133] |
Palmatine | Alkaloid | Coptis chinensis | Inhibited DENV replication (EC50 = 26.4 µmol/L) | [134] |
Panduratin A | Phenolic derivative | Boesenbergia rotunda | Competitive inhibitory activity against DENV-2 NS3 protease (K1 = 25 µM) | [37] |
Pectolinarin | Flavone | Distictella elongate | Good anti-DENV-2 effect (EC50 = 86.4 µg/mL) |
[101] |
Pinostrobin | Flavanone | Boesenbergia rotunda | Non-competitive DENV replication inhibitory activity | [37] |
Quercetin | Flavonoid | Houttuynia cordata | Anti-DENV-2 effect at 500 µg/mL (IC50 = 176.76 µg/mL) | [108] |
Quercetin | Flavonol | Houttuynia cordata | Synergistic antiviral effect of quercetirin and quercetin combination | [109] |
Spondias mombin and Spondias tuberosa | Inhibited viral replication (50%) of DENV-2 at 500 µg/mL | [85] | ||
Quercetirin | Flavonoid glycoside | Houttuynia cordata | Exhibited less activity in an uncombined form compared to its mixture with quercetin (IC50 = 467.27 µg/mL) |
[108] |
Houttuynia cordata | Synergistic antiviral effect of quercetirin and quercetin combination. greater antiviral effects | [109] | ||
Rutin | Flavonol glycoside | Spondias mombin and Spondias tuberosa | Inhibited viral replication of DENV-2 at 500 µg/mL by 68.42% | [85] |
Scolochinenoside D | Phenolic glycoside | Flacourtia ramontchi | Inhibited DENV replication (IC50 = 9.5 µM) |
[103] |
Trigocherrin A | Diterpenoid | Trigonostemon cherrieri | Inhibited DENV replication (IC50 = 12.7 µM) |
[128] |
Trigocherriolide B | Diterpenoid | Trigonostemon cherrieri | Inhibited DENV replication (IC50 = 3.1 µM) |
[128] |
Trigocherriolide C | Diterpenoid | Trigonostemon cherrieri | Inhibited DENV replication (IC50 = 16.0 µM) |
[128] |
Ursolic acid | Triterpenoid | Arrabidaea pulchra | Displayed anti-DENV-2 (IC50 = 3.2 µg/mL) |
[84] |
Verbascoside | Phenyl glycoside | Arrabidaea pulchra | Displayed anti-DENV-2 (IC50 = 3.4 µg/mL) |
[84] |
Baicalein | Bioflavonoid | Scutellaria baicalensis | Displayed anti-DENV-2 (IC50 = 1.55 μg/mL) |
[135] |
Zosteric acid | Phenolic acid | Zostera marina | Displayed anti-DENV-2 (IC50 = 2.3 mM) |
[136] |
Abbreviations: EC50, median effective concentration; IC50, median inhibitory concentration; DENV, dengue virus; DENV-1, dengue virus type-1; DENV-2, dengue virus type 2, DENV-3, dengue virus type 3, DENV-4, dengue virus type 4, RdRp, RNA-dependent RNA polymerase; NS3, nonstructural protein 3.